作者
Kaisa M Mäki-Petäjä, Maysoon Elkhawad, Joseph Cheriyan, Francis R Joshi, Andrew JK Östör, Frances C Hall, James HF Rudd, Ian B Wilkinson
发表日期
2012/11/20
期刊
Circulation
卷号
126
期号
21
页码范围
2473-2480
出版商
Lippincott Williams & Wilkins
简介
Background
Rheumatoid arthritis (RA) is a systemic inflammatory condition associated with increased cardiovascular risk. This is not fully explained by traditional risk factors, but direct vascular inflammation and aortic stiffening may play a role. We hypothesized that patients with RA exhibit aortic inflammation, which can be reversed with anti-tumor necrosis factor-α therapy and correlates with aortic stiffness reduction.
Methods and Results
Aortic inflammation was quantified in 17 patients with RA, before and after 8 weeks of anti-tumor necrosis factor-α therapy by using 18F-fluorodeoxyglucose positron emission tomography with computed tomography coregistration. Concomitantly, 34 patients with stable cardiovascular disease were imaged as positive controls at baseline. Aortic fluorodeoxyglucose target-to-background ratios (TBRs) and aortic pulse wave velocity were assessed. RA patients had higher baseline …
引用总数
2012201320142015201620172018201920202021202220232024222363131242710161716135